TITLE

Beating Cervical Cancer

AUTHOR(S)
Fahey, Jonathan
PUB. DATE
October 2005
SOURCE
Forbes Asia;10/31/2005, Vol. 1 Issue 6, p16
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the results of the trial for a vaccine that could prevent human papilloma virus (HPV) which causes genital warts and cervical cancer conducted by Merck. 100 percent of women who received the vaccine were protected against HPV. An estimated 20 million men and women in the U.S. acquired HPV through sex. The company plans to apply for regulatory approval for the vaccine.
ACCESSION #
21027890

 

Related Articles

  • A QUIET INFECTION. Fern├índez, Sara; Zuellig, Alissa // Hispanic;May2007, Vol. 20 Issue 4, p26 

    The article reports on the discovery of a new vaccine called Gardasil to prevent diseases caused by human papillomavirus (HPV). According to the article, although Gardasil, manufactured by the pharmaceutical company Merck, targets four types of HPV that together cause 70 percent of cervical...

  • HPV jab "within 2 years".  // Practice Nurse;4/29/2005, Vol. 29 Issue 8, p8 

    Focuses on a clinical trial for Gardasil, a vaccine developed by Merck against cervical cancer and genital warts. Findings of the trial on its therapeutic use; Views of researchers on the effectivity of the human papilloma virus vaccination.

  • Vaccine against cervical cancer.  // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Dec2006, Vol. 13 Issue 6, p800 

    The article reports on the receipt of a European license by Gardasil vaccine in Great Britain. The vaccine, prepared by Merck and Sanofi Pasteur, is active against the human papilloma virus (HPV) which is a cause of cervical cancer. It is designed for girls and women aged 9-26 years and will...

  • Cervical cancer breakthrough.  // European Pharmaceutical Executive;Nov/Dec2005, p12 

    The article reports that an investigational vaccine from Merck & Co. Inc. has been shown to be 100 percent effective against two virus strains which cause the most incidences of cervical cancer. The phase III trial found that Gardasil prevents high-grade cervical pre-cancers and non-invasive...

  • Gardasil's Use in Men Studied.  // Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p57 

    The article presents a study published in the "New England Journal of Medicine" which found Gardasil to be 89% effective against human papillomavirus (HPV)-related genital warts in men ages 16-26, according to Merck & Co. Inc.

  • Sorry Kids, Another Shot!  // State Legislatures;Jan2007, Vol. 33 Issue 1, p7 

    The article reports on Merck's Gardasil and GlaxoSmithKline's Cervarix vaccines to fight human papilloma virus (HPV) causing cervical cancer and genital warts. The U.S. Food and Drug Administration approved Gardasil vaccine for females between 9 and 26. The Centers for Disease Control recommends...

  • Merck's Lybrand Plays It Cool In Midst of Hot Controversy. Edwards, Jim // Brandweek;4/16/2007, Vol. 48 Issue 16, p5 

    The article examines the controversy surrounding Gardasil, which is a vaccine for HPV, genital warts and cervical cancer that is administered to teenage girls. The article reports that Merck, the company that distributes the drug, first ran into controversy when it began a lobbying campaign to...

  • Success for Cervical Cancer Vaccine. Grose, Simon // Australasian Science;Aug2007, Vol. 28 Issue 7, p39 

    The article discusses the findings of clinical trials of Gardasil vaccine from Merck to protect young women against infection by four strains of human papillomavirus (HPV) linked to cervical cancer. A study found that there are possible linkages between cancers of the upper throat and HPV...

  • In The News: HPV jab success. Dell, Helen // Nature Reviews Cancer;May2005, Vol. 5 Issue 5, p334 

    The article focuses on vaccine targeting four strains of human papillomavirus (HPV). It has reduced infection rates by 90% compared with a placebo in a randomized, double-bline trial. The vaccine was purposefully designed to target the HPV types most commonly associated with cervical cancer, as...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics